Article
Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.
Cellular oncology (Dordrecht, Netherlands) - 1 Oct 2017
Beije Nick, Kraan Jaco, den Bakker Michael A, Maat Alexander P W M, van der Leest Cor, Cornelissen Robin, Van Ngoc M, Martens John W M, Aerts Joachim G J V, Sleijfer Stefan
Abstract excerpt
PURPOSE: There is a lack of robust and clinically utilizable markers for the diagnosis and prognostication of malignant pleural mesothelioma (MPM). This research was aimed at optimizing and exploring novel approaches to improve the diagnosis and prognostication of MPM in pleural effusions and peripheral blood samples. METHODS: CellSearch-based and flow cytometry-based assays using melanoma cell adhesion molecule...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.